Mayo Clinic Laboratory and Pathology Research Roundup: August 12

By Samantha Rossi • August 12, 2019

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).

Genetic modulation of drug response can cause life-threatening adverse drug reactions, increase susceptibility to drug interactions and alter therapeutic effectiveness. Pharmacogenomics has the potential to immediately impact the care of patients and is a hallmark of genomic medicine worldwide. Ideally, pharmacogenomics-guided drug selection will produce optimal effects for specific indications, reduce delays in care to effective therapies, improve patient safety and reduce health care costs. Over the past decade, a large number of pharmacogenomic variants with demonstrated clinical utility have been identified and corresponding international guidelines for clinical implementation have been developed and published by the Clinical Pharmacogenetics Implementation Consortium (CPIC), Canadian Pharmacogenomics Network for Drug Safety (CPNDS) and Royal Dutch Association for the Advancement of Pharmacy Dutch Pharmacogenetics Working Group (DPWG). There is now general agreement that pharmacogenomics represents an area within genomic science that could have a significant positive impact on clinical medicine and, ultimately, affect every patient. Via The International Journal of Epidemiology.

Read more.

Published to PubMed This Week

• Autoimmune Gait Disturbance Accompanying Adaptor Protein-3B2-IgG.
  Neurology
• Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay.
  Clinical Chemistry
• Ovarian Fibrothecoma.
  Mayo Clinic Proceedings
• Etiologies of Extreme Thrombocytosis: A Contemporary Series.
  Mayo Clinic Proceedings
• Association of Elevated Serum Free Light Chains with Chronic Lymphocytic Leukemia and Monoclonal B-cell Lymphocytosis.
  Blood Cancer Journal
• Genetic Predictors of Chemotherapy-Related Amenorrhea in Women with Breast Cancer.
  Fertility and Sterility
• Fresh Versus Frozen Embryo Transfer Has No Effect on Childhood Weight.
  Fertility and Sterility
• Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
  Journal of Neuropathology and Experimental Neurology
• Hb Gibbon [β124(H2)Pro→Thr (<i>HBB</i>: c.373C>A, p.P125T)], an Asymptomatic Novel Hemoglobin Variant Detected by Newborn Screening.
  Hemoglobin
• Endoscopic Findings of Esophageal Submucosal Gland Duct Adenoma.
  VideoGIE

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.